What Researchers Did
Researchers described the aggressive surgical and medical treatment, including adjunctive hyperbaric oxygen, of a 66-year-old man with bilateral cerebro-rhino-orbital mucormycosis.
What They Found
A 66-year-old man with bilateral cerebro-rhino-orbital mucormycosis and newly diagnosed nonketotic diabetes mellitus received aggressive treatment including bilateral orbital exenteration, intravenous and local amphotericin B, hyperbaric oxygen, and diabetes control. One and a half years after onset, the patient remained alert and clinically stable, an uncommon outcome for this often fatal disease.
What This Means for Canadian Patients
This case suggests that aggressive, multi-modal treatment, potentially including hyperbaric oxygen, could improve survival for Canadian patients diagnosed with severe mucormycosis. Prompt diagnosis and comprehensive management are crucial for individuals facing this life-threatening infection.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, this study's findings have limited generalizability to a wider patient population.